Comments of the Healthcare Supply Chain Association (HSCA) on USTR Request for Comments on the Proposed Modification of Action Pursuant to Section 301
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on the proposed modification of action regarding Chinese exports under Section 301.
Click here for the full comments.
Related Posts
HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
October 5, 2020
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Names Leading National Healthcare Expert Khatereh Calleja as President & CEO
April 2, 2019
Washington, DC (April 2, 2019) – The Healthcare Supply Chain Association (HSCA)...
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 11, 2019
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Letter to the House Committee on Energy and Commerce
July 30, 2020
Dear Chairman Pallone and Ranking Member Walden: On behalf of the Healthcare...